|
KIF3C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.35830000000692E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.637800E-02 |
| Normal-vs-Stage2 |
4.996100E-02 |
| Normal-vs-Stage3 |
9.480400E-03 |
| Normal-vs-Stage4 |
2.109600E-01 |
| Stage1-vs-Stage2 |
4.537000E-01 |
| Stage1-vs-Stage3 |
5.006200E-02 |
| Stage1-vs-Stage4 |
3.328000E-01 |
| Stage2-vs-Stage3 |
2.074800E-01 |
| Stage2-vs-Stage4 |
4.881600E-01 |
| Stage3-vs-Stage4 |
9.434000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.607600E-04 |
| Normal-vs-AfricanAmerican |
3.078000E-02 |
| Normal-vs-Asian |
9.401800E-02 |
| Caucasian-vs-AfricanAmerican |
8.078400E-01 |
| Caucasian-vs-Asian |
8.366600E-01 |
| AfricanAmerican-vs-Asian |
5.904400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.506220E-01 |
| Normal-vs-Female |
9.39129999988353E-07 |
| Male-vs-Female |
1.83561000000054E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.865640E-02 |
| Normal-vs-Extreme_Weight |
9.919600E-01 |
| Normal-vs-Obese |
9.896500E-03 |
| Normal-vs-Extreme_Obese |
4.751000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.961730E-02 |
| Normal_Weight-vs-Obese |
5.302200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.488040E-01 |
| Extreme_Weight-vs-Obese |
1.153950E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.405200E-01 |
| Obese-vs-Extreme_Obese |
2.722200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.289700E-02 |
| Normal-vs-Age(41-60Yrs) |
7.369900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.062200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.870400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.319170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.602100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.770110E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.475200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.420900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.486000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.720800E-01 |
| Normal-VS-Type2 PRCC |
1.872210E-02 |
| Normal-VS-KIRP CIMP |
3.336300E-03 |
| Normal-VS-Unclassified PRCC |
7.167500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.445800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.296300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.478300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
8.276700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.135200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.473880E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.369700E-02 |
| Normal-vs-N1 |
5.936500E-03 |
| Normal-vs-N2 |
1.985770E-01 |
| N0-vs-N1 |
3.079700E-02 |
| N0-vs-N2 |
2.557200E-01 |
| N1-vs-N2 |
5.740600E-01 |
|
|
